NPRA’s Drug Safety Alert: Ischaemic colitis associated with Nintedanib use

Drug Safety Alert, Drug Safety Signal, Drug Safety Updates, Pharmacovigilance, Safety Communications, , ,

The Malaysian Health Authority-National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia released a new drug safety alert for nintedanib. Nintedanib is a small molecule tyrosine kinase inhibitor (TKI) indicated for the treatment of idiopathic pulmonary fibrosis in adults and to slow the rate of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung…

Read More

Drug Safety Alerts from Malaysian Health Authority

Drug Safety Alert, Drug Safety Signal, Drug Safety Updates, Global Safety Alerts, NPRA-Malaysia, Pharmacovigilance, Safety Communications, ,

The Malaysian Health Authority-National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia released the following new drug safety alerts. Drug Safety Alert 1: Risk of anaphylaxis associated with Guselkumab use Drug Safety Alert 2: Kounis syndrome associated with Intravenous iron-containing products Drug Safety Alert 3: Reports of cytomegalovirus (CMV) infection or reactivation with Nivolumab use…

Read More

error: Content is protected !!